Literature DB >> 11408065

Pattern of chromosomal imbalances in non-B virus related hepatocellular carcinoma detected by comparative genomic hybridization.

M A Collonge-Rame1, S Bresson-Hadni, S Koch, J P Carbillet, O Blagosklonova, G Mantion, J P Miguet, B Heyd, J L Bresson.   

Abstract

Only limited data are available on comparative genomic hybridization (CGH) in hepatocellular carcinoma (HCC). They concern mainly B virus related HCC. Therefore, we used CGH to detect chromosomal imbalances in 16 non-B virus related HCC in alcoholic cirrhosis in 7 cases (HA1 to HA7), in C virus cirrhosis in 7 cases (HC1 to HC7), in non-cirrhotic liver in 2 cases (NC1, NC2), and in 9 non-malignant cirrhotic tissues. The most frequent imbalances in HCC were gains of whole chromosomes or chromosomal regions 7 or 7q (10/16, 62%), 1q (9/16, 56%), 5 or 5q (9/16, 56%), 8q (8/16, 50%), 6p (6/16, 37%), 15q (5/16, 31%), 20 or 20q (5/16, 31%), and losses of 17p (6/16, 37%), and 8p (5/16, 31%). High-level gains were identified in HCC on 1q (2/16), 3q (1/16), 7q (1/16), and 8q (3/16). No chromosomal imbalances were detected in any of the cirrhotic tissues. Most of the gains, losses, and amplifications detected in this CGH study corresponded well to those identified in previous studies, except for gains of whole chromosome 5 or 7 and/or of chromosome arms 5q or 7q and losses on 4q. Our results suggest that other chromosomal regions are involved in hepatocarcinogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11408065     DOI: 10.1016/s0165-4608(00)00421-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Development of hepatocellular carcinoma following treatment with 6-mercaptopurine for ulcerative colitis: investigation of chromosomal aberration by comparative genomic hybridization.

Authors:  Kentaro Nakao; Akira Tsunoda; Yoshinori Shimizu; Koji Takenaka; Koji Morohara; Naoto Suzuki; Katsuo Yamazaki; Takeshi Aoki; Mitsunori Hoshino; Mitsuo Kusano; Eri Kitadai; Toshikazu Kurihara; Yoshiaki Takeuchi; Michio Imawari
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

Review 2.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

3.  Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1.

Authors:  Alexandra Klein; Daniela Flügel; Thomas Kietzmann
Journal:  Mol Biol Cell       Date:  2008-06-18       Impact factor: 4.138

4.  Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma.

Authors:  Felix H Shek; Sarwat Fatima; Nikki P Lee
Journal:  Int J Hepatol       Date:  2012-09-18

5.  Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility.

Authors:  Masahiko Tameda; Kazushi Sugimoto; Katsuya Shiraki; Norihiko Yamamoto; Ryuji Okamoto; Masanobu Usui; Masaaki Ito; Yoshiyuki Takei; Tsutomu Nobori; Takahiro Kojima; Hideaki Suzuki; Masako Uchida; Kazuhiko Uchida
Journal:  Int J Oncol       Date:  2014-05-19       Impact factor: 5.650

6.  Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17.

Authors:  Stephanie E-M Peychal; Andrea Bilger; Henry C Pitot; Norman R Drinkwater
Journal:  Carcinogenesis       Date:  2009-03-02       Impact factor: 4.944

7.  Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data.

Authors:  Joseph J Crawley; Kyle A Furge
Journal:  Genome Biol       Date:  2002-11-25       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.